PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
115 hedge funds and large institutions have $99.9M invested in Provention Bio, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
43% less capital invested
Capital invested by funds: $176M → $99.9M (-$76.5M)
Holders
115
Holding in Top 10
–
Calls
$3.17M
Puts
$842K
Top Buyers
| 1 | +$2.37M | |
| 2 | +$857K | |
| 3 | +$763K | |
| 4 |
Renaissance Technologies
New York
|
+$667K |
| 5 |
DCM
DG Capital Management
New York
|
+$400K |
Top Sellers
| 1 | -$2.72M | |
| 2 | -$816K | |
| 3 | -$505K | |
| 4 |
Nisa Investment Advisors
St. Louis,
Missouri
|
-$332K |
| 5 |
AI
Atom Investors
Austin,
Texas
|
-$312K |